iPSC Differentiation for Curative Regenerative Cell Therapies of the Future

iPSC Differentiation for Curative Regenerative Cell Therapies of the Future

iPSC Differentiation for Curative Regenerative Cell Therapies of the Future

Learn how induced pluripotent stem cells (iPSCs) are being developed into potentially life-changing therapies.

If you missed the live session, you can now watch the full webinar on demand.

In this session, Catalina Gomez-Puerto, PhD shares her knowledge on induced pluripotent stem cells (iPSCs) and their role in regenerative medicine. The discussion covers key aspects of iPSC differentiation, challenges in the field, and real-world applications, including Beta Cells, Dopaminergic Neurons, and RPE Cells.

What You’ll Learn in the Replay:
– A practical overview of iPSC development and workflows

– ⁠Methods and approaches for guiding iPSCs into specific cell types

– Case studies on iPSC-derived cell therapies

– An update on current clinical advancements

If you have additional questions, we invite you to share your questions.

Webinar Product Quality for Cell Therapies

Webinar Product Quality for Cell Therapies

Product Quality For Cell Therapies

This session is set to be a compelling exploration of product quality in Cell Therapies.

Key areas of focus include:

As the field of regenerative medicine and Cell Therapies advances, it underscores a longstanding imperative: the quality, safety, and efficacy of these products has always been and remains the most crucial aspect of any therapy.

While a multi-faceted approach to quality is a standard across various therapies, Cell Therapies present unique challenges due to their nature as living therapies. Specifications for these products will inherently exhibit a range because they are derived from living cells. Consequently, testing strategies for Cell Therapies are more risk-based and require a tailored approach when compared to non-Advanced Therapy Medicinal Products (non-ATMPs).

  • Understanding Cell Therapies
  • The Importance of Product Quality
  • Building a Quality Strategy
  • Testing and Validation
  • Regulatory Landscape

Our experts can provide insights and answer your queries to advance your cell therapy development. This webinar is designed to help you explore and navigate the complexities of product quality strategies for cell therapies. If you have additional questions, we invite you to share them.

Webinar iPSC Banking & Derivation

Webinar iPSC Banking & Derivation

iPSC Banking & Derivation

Ever wondered how to transition from bench to GMP suitable processes in the iPSC-derived therapies field? Yes? Watch the webinar replay on iPSC Derivation & Banking.

Key areas of focus include:

  • Transitioning from Bench to GMP Suitable Processes
  • Identifying Technologies for Scale-Up and Future Manufacturing
  • New GMP iPSC Generation
  • Master and Working Cell Bank Creation
  • Quality Control Strategies for Safe Products

Our experts can provide insights and answer your queries to advance your therapy development. This webinar is designed to help you explore and navigate the complexities of iPSC therapy development, but if you have additional questions, we invite you to ask us your questions.

NecstGen Services

Cell Therapy Development & Manufacturing

Viral Vector Development & Manufacturing

Consultancy

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.

About Us

Partners

History

Facility

Ecosystem